Trial Profile
A Multicenter Trial to Assess the MIcrovascular Integrity and Left Ventricular Function Recovery After Clopidogrel or TicagrelOr Administration, in Patients With STEMI Treated With Thrombolysis - The 'MIRTOS' Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Feb 2019
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Ticagrelor (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms MIRTOS
- 06 Feb 2019 Status changed from active, no longer recruiting to completed.
- 06 Sep 2018 Planned End Date changed from 1 Dec 2017 to 1 Jan 2019.
- 06 Sep 2018 Planned primary completion date changed from 1 Sep 2017 to 1 Oct 2018.